LifeScience Clinical & Diagnostic
Bio Sourcing And Tiny Cargo Partner To Develop Oral Monoclonal Antibody Therapies Using Milk Derived Exosomes
Bio‑Sourcing SA (‘Bio-Sourcing’) and The Tiny Cargo Company (‘Tiny Cargo’) today announce a strategic collaboration to co‑devel...
March 31, 2026 | News
Matricelf And CiRA Foundation Partner To Advance Scalable iPSC Based Neural Tissue Manufacturing
Matricelf Ltd. (TASE: MTLF), a biotechnology company developing a novel autologous engineered neural tissue therapy for patients with spinal cord injury, a...
March 31, 2026 | News
Neurophet Partners With ALZ NET To Advance AI Driven Imaging In Alzheimer’s Care
Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions Collaboration expected to ...
March 31, 2026 | News
AstraZeneca Reports Positive Phase 3 Results For Tozorakimab In COPD
Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozoraki...
March 30, 2026 | News
Anumana Secures FDA Clearance For AI Algorithm Enabling Early Detection Of Pulmonary Hypertension
Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm...
March 30, 2026 | News
Bioptimus Launches STELA Initiative To Build World’s Largest Multimodal Atlas For AI Driven Biology
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale...
March 27, 2026 | News
Akeso Advances IO 2.0 Plus ADC 2.0 Strategy With Phase II Trial Clearance In China
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that it has received clearance from the Center for Drug Evaluation (CDE) of China's ...
March 26, 2026 | News
Innovent Advances Tigulixostat Into Phase 3 To Challenge Standard Gout Therapy
Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality med...
March 24, 2026 | News
Everest Medicines Acquires CARDAMYST Rights To Strengthen Cardiovascular Portfolio In Greater China
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...
March 24, 2026 | News
ImmunityBio Secures Macau Approval For ANKTIVA In BCG Unresponsive Non Muscle Invasive Bladder Cancer
Macau SAR, China regulator grants approval for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in patients with BCG-unresponsive NMIBC with CIS &plusm...
March 23, 2026 | News
GI Innovation Enters Clinical Supply Agreement With Johnson And Johnson To Advance Prostate Cancer Combination Therapy
GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy...
March 23, 2026 | News
Alphamab Oncology Initiates Phase 3 Study Of Bispecific ADC JSKN016 In Triple Negative Breast Cancer
Alphamab Oncology announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispec...
March 23, 2026 | News
Everest Medicines Eyes Strategic Asia Expansion With Proposed Hasten Singapore Acquisition
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...
March 19, 2026 | News
Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation
Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...
March 18, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
